COVID-Net S: Towards computer-aided severity assessment via training and
  validation of deep neural networks for geographic extent and opacity extent
  scoring of chest X-rays for SARS-CoV-2 lung disease severity
  Background: A critical step in effective care and treatment planning for
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the
COVID-19 pandemic, is the assessment of the severity of disease progression.
Chest x-rays (CXRs) are often used to assess SARS-CoV-2 severity, with two
important assessment metrics being extent of lung involvement and degree of
opacity. In this proof-of-concept study, we assess the feasibility of
computer-aided scoring of CXRs of SARS-CoV-2 lung disease severity using a deep
learning system.
  Materials and Methods: Data consisted of 396 CXRs from SARS-CoV-2 positive
patient cases. Geographic extent and opacity extent were scored by two
board-certified expert chest radiologists (with 20+ years of experience) and a
2nd-year radiology resident. The deep neural networks used in this study, which
we name COVID-Net S, are based on a COVID-Net network architecture. 100
versions of the network were independently learned (50 to perform geographic
extent scoring and 50 to perform opacity extent scoring) using random subsets
of CXRs from the study, and we evaluated the networks using stratified Monte
Carlo cross-validation experiments.
  Findings: The COVID-Net S deep neural networks yielded R$^2$ of 0.664 $\pm$
0.032 and 0.635 $\pm$ 0.044 between predicted scores and radiologist scores for
geographic extent and opacity extent, respectively, in stratified Monte Carlo
cross-validation experiments. The best performing networks achieved R$^2$ of
0.739 and 0.741 between predicted scores and radiologist scores for geographic
extent and opacity extent, respectively.
  Interpretation: The results are promising and suggest that the use of deep
neural networks on CXRs could be an effective tool for computer-aided
assessment of SARS-CoV-2 lung disease severity, although additional studies are
needed before adoption for routine clinical use.
